The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear
The FDA shared an alert about off-brand injectable semaglutide products.
Peter Hansen/Getty Images
- The FDA said people may be overdosing on knock-off semaglutide weight-loss drugs.
- Consumers are self-administering incorrect doses.
- Reports found some people administered 5 to 20 times more semaglutide than intended.
The US Food and Drug Administration says some people have been hospitalized with symptoms that may be related to overdoses from injectable weight-loss drugs.
Заголовки